Fisher HealthCare becomes exclusive distributor of Flow Cytometry Reagents for Dako Reagent Partnership Division

05-06-2009: Dako, Reagent Partnership Division, has entered into a five-year agreement with Fisher HealthCare, a division of Thermo Fisher Scientific. Under this agreement, Fisher Healthcare has been granted the exclusive right to distribute Flow Cytometry reagents in the US acute care market, including hospitals and reference labs.

Christian Kjaer, Vice President, Reagent Partnership Division of Dako, said: "We are delighted to be partnering with Fisher HealthCare to bring outstanding customer service to our customers along with a broad portfolio of world-class product solutions. The agreement furthers Dako's commitment to the growing cancer diagnostics market by strengthening and enlarging the Dako sales channel."

Mark Smits, Vice President, Marketing of Fisher HealthCare, said: "This partnership broadens our cancer-based diagnostic portfolio and allows us to provide a more comprehensive product offering to our customers. We will be better positioned to meet the needs of this market by capitalizing on Dako's long history of quality Flow Cytometry reagents and commitment to the diagnostic market."

Facts, background information, dossiers
  • cancer diagnostics
More about Dako
More about Thermo Fisher Scientific
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE